Tower Research Capital LLC (Trc) Lian Bio Transaction History

Tower Research Capital LLC (Trc)

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$1.79 - $2.85 $1,571 - $2,502	878 New	878 $2,000
Q4 2022 Feb 10, 2023	SELL	$1.14 - $2.11 $13,969 - $25,855	-12,254 Reduced 58.99%	8,519 $14,000
Q3 2022 Nov 10, 2022	BUY	$1.87 - $3.0 $36,681 - $58,848	19,616 Added 1695.42%	20,773 $41,000
Q2 2022 Aug 15, 2022	SELL	$2.15 - $6.01 $10,203 - $28,523	-4,746 Reduced 80.4%	1,157 $3,000
Q1 2022 May 12, 2022	BUY	$2.8 - $6.21 $16,528 - $36,657	5,903 New	5,903 $22,000

1.1M

Ticker LIAN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 108,354,000
Market Cap $32.5M
Description
LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with p...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.